This purpose of this thread is to highlight US or Canadian shares that I either hold or am following that may be of interest to others.

Links to the company websites are in green.

3D Systems - Thread here

Atlantic Power

Statasys

Organavo

Tesla

Update: Atlantic Power Dividend Cut - Investors Might Need To Look Elsewhere For Growth And Income

Summary

The company today announced another dividend cut which brings down its annual dividend substantially.

Atlantic Power continues to face issues regarding its cash flows.

Another dividend cut has altered our opinion and investors might need to look elsewhere for growth and income.

ATP back above $3.

Stratasys: Major Warning Sets Up Future Buying Opportunity

-28.5% last night.

Stratasys Collapse Asks If 3D Printing Boom Has Busted

Summary

Stratasys shares plunged 25% overnight.

The problems were mainly at MakerBot, which represents 12% of sales.

With the speculative fever broken, you can now make an investment decision on the company.

ATP currently up 7%.

ONVO could be interesting today :-

Micro cap Organovo (NYSEMKT:ONVO) is up 10% premarket on average volume in response to its announcement that it presented data on in vitro three-dimensional kidney tissue at the Experimental Biology conference in Boston.

The 3D tissue, fabricated using the company's NovoGen bioprinter, consists of multiple tissue-relevant cell types arranged to recapitulate the renal tubular/interstitial interface, specifically polarized renal proximal tubular epithelial cells and a living interstitial layer of renal fibroblasts and endothelial cells.

Analyzing the tissue on a slide under a microscope showed evidence of formation of microvascular structures and stable maintenance of the layered architecture for at least two weeks.

Organovo (NYSEMKT:ONVO) enters into a multi-year collaboration agreement with Merck (NYSE:MRK) to develop multiple custom tissue models. The deal includes access to
ONVO's exVive3D Human Liver Tissue service. Financial terms are not disclosed.

ONVO is up 17% premarket on robust volume.

Gap closure within sight on ATP.